ACM
ADAR1 Capital Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.56M | Sell |
535,066
-433,800
| -45% | -$6.94M | 1.31% | 17 |
|
|
2025
Q1 | $16.6M | Buy |
968,866
+181,388
| +23% | +$3.1M | 3.07% | 5 |
|
|
2024
Q4 | $19.5M | Sell |
787,478
-344,229
| -30% | -$8.53M | 3.9% | 5 |
|
|
2024
Q3 | $32.3M | Buy |
1,131,707
+655,164
| +137% | +$18.7M | 5.25% | 6 |
|
|
2024
Q2 | $12.6M | Buy |
476,543
+415,780
| +684% | +$11M | 2.38% | 8 |
|
|
2024
Q1 | $1.96M | Sell |
60,763
-73,362
| -55% | -$2.37M | 0.45% | 39 |
|
|
2023
Q4 | $5.65M | Buy |
+134,125
| New | +$5.65M | 2.02% | 11 |
|